Der Kaninchen Polyklonal anti-NIBAN2 Antikörper wird verwendet zum Nachweis von NIBAN2 in Proben von Human, Maus und Ratte. Er wurde validiert für ELISA, IHC, WB und FACS.
Kurzübersicht für NIBAN2 (AA 23-561) Antikörper (ABIN7825606)
Target
NIBAN2
Reaktivität
Human, Maus, Ratte
Wirt
Kaninchen
Klonalität
Polyklonal
Applikation
ELISA, Immunohistochemistry (IHC), Western Blotting (WB), Flow Cytometry (FACS)
Bindungsspezifität
AA 23-561
Verwendungszweck
Anti-FAM129B/NIBAN2 Antibody
Kreuzreaktivität (Details)
No cross-reactivity with other proteins.
Produktmerkmale
Anti-FAM129B/NIBAN2 Antibody catalog # A09391-2. Tested in ELISA, Flow Cytometry, IHC, WB applications. This antibody reacts with Human, Mouse, Rat. This is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications.
Aufreinigung
Immunogen affinity purified.
Immunogen
E.coli-derived human FAM129B/NIBAN2 recombinant protein (Position: K23-K561).
Isotyp
IgG
Applikationshinweise
Western blot, 0.25-0.5 μg/mL, Human, Mouse, Rat Immunohistochemistry(Paraffin-embedded Section), 2-5 μg/mL, Human Flow Cytometry (Fixed), 1-3 μg/1x106 cells, Human ELISA, 0.1-0.5 μg/mL, -
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
At -20°C for one year from date of receipt. After reconstitution, at 4°C for one month. It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freezing and thawing.
Target
NIBAN2
Hintergrund
FAM129B/Niban-like protein 1 (family with sequence similarity 129, member B) belongs to a poorly characterized family of Niban proteins that also includes FAM129A/Niban and FAM129C/Niban-like protein 2. FAM129A/Niban is implicated in the ER stress response and is upregulated at the protein level in thyroid carcinoma. FAM129C/Niban-like protein 2 is preferentially expressed in B-cells and is one of five biomarkers upregulated in whole blood from patients with colorectal carcinoma. FAM129B is broadly expressed and has been shown to be a downstream target of B-Raf in melanoma cells. Though FAM129B does not appear to regulate cell growth and division, phosphorylation of FAM129B by B-Raf is essential for the invasive potential of melanoma and non-melanoma cell lines. Deletion of FAM129B in melanoma cells significantly impairs B-Raf/MEK/Erk-dependent invasion into the extracellular matrix.